Equity Capital Markets

Company · CIK 1581720

Loxo Oncology, Inc.

CIK1581720 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCT
Listedno ticker on SEC record today
First annual or quarterly report2014-09-12

Offerings

4 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-214392
ShelfEffective
 2016-11-022019-02-215
333-218690
ShelfEffective
 2017-06-132017-06-153
333-206052
ShelfEffective
 2015-08-032016-05-126
333-197123
IPOFinal prospectus
 2014-06-302014-08-015

Filings

20
FiledFilingRegistrationAccession
2019-02-21EFFECTDeclared effective 333-2143929999999995-19-000306
2017-06-15424B5Shelf takedown 333-2186900001047469-17-004040
2017-06-13424B5Shelf takedown 333-2186900001047469-17-003971
2017-06-13S-3ASRShelf registered 333-2186900001047469-17-003969
2017-01-05424B5Shelf takedown 333-2143920001047469-17-000067
2017-01-04424B5Shelf takedown 333-2143920001047469-17-000039
2016-11-16EFFECTDeclared effective 333-2143929999999995-16-006252
2016-11-02S-3Shelf registered 333-2143920001104659-16-154204
2016-05-12424B5Shelf takedown 333-2060520001047469-16-013108
2016-05-11424B5Shelf takedown 333-2060520001047469-16-013095
2015-11-12424B5Shelf takedown 333-2060520001047469-15-008579
2015-11-12424B5Shelf takedown 333-2060520001047469-15-008547
2015-08-11EFFECTDeclared effective 333-2060529999999995-15-002256
2015-08-03S-3Shelf registered 333-2060520000912057-15-000234
2014-08-01424B4Final prospectus 333-1971230001047469-14-006588
2014-07-31EFFECTDeclared effective 333-1971239999999995-14-002342
2014-07-30S-1/AAmendment 333-1971230001047469-14-006498
2014-07-21S-1/AAmendment 333-1971230001047469-14-006303
2014-06-30S-1Registration filed 333-1971230001047469-14-005954
2014-05-14DRSDraft made public 377-006220000912057-14-000164

All filings of this company · CSV